← Browse by Condition
Medical Condition

relapsed refractory acute myeloid leukaemia

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT04501120 Phase 1, Phase 2
Recruiting

Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML

Enrollment
458 pts
Location
China
Sponsor
Ascentage Pharma Group Inc.
View Trial →